Instil Bio Inc

NASDAQ:TIL   3:59:55 PM EDT
18.48
-0.75 (-3.90%)
Earnings Announcements

Instil Bio Reports Second Quarter 2021 Financial Results And Provides Corporate Update

Published: 08/12/2021 11:35 GMT
Instil Bio Inc (TIL) - Instil Bio Reports Second Quarter 2021 Financial Results and Provides Corporate Update.
Instil Bio Inc - Expects Cash and Cash Equivalents As of June 30, 2021 Will Enable It to Fund Its Operating Plan Into 2023.
Instil Bio Inc Qtrly Net Loss per Share, Basic and Diluted $0.27.
Revenue is expected to be $0 Million
Adjusted EPS is expected to be -$0.31

Next Quarter Revenue Guidance is expected to be $0 Million
Next Quarter EPS Guidance is expected to be -$0.37

More details on our Analysts Page.